 |
|
|
| |
Implications of Baseline HCV RNA Level and Intrapatient Viral Load
Variability on OBV/PTV/r + DSV 12-Week Treatment Outcomes
|
| |
| |
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Robert S Brown Jr1, Massimo Puoti 2, Curtis Cooper3, David L Wyles4, Thomas E Sepe5, Ronald G Nahass6,
Eoin Coakley7, Martin King7, Jordan J Feld8
1Columbia University Medical Center, Center for Liver Disease and
Transplantation, New York, New York, United States; 2AO Ospedale Niguarda Ca Granda, Milan, Italy; 3University of Ottawa, Ottawa, Ontario, Canada; 4University of California San Diego, La Jolla, California, United States; 5Liver Center, University Gastroenterology, Providence, Rhode Island, United States; 6ID Care, Hillsborough, New Jersey, United States; 7AbbVie Inc., North Chicago, Illinois, United States; 8University of Toronto, Toronto, Ontario, Canada
|
| |
|
|
|
|
|
